ARID1A interacts with Rb to prevent CDK‐mediated Rb phosphorylation, inhibit E2F transcription factor 1 (E2F1) activity, and subsequently inhibit c‐Myc transcription, revealing a new mechanism of ARID1A in squamous cell carcinoma (SCC). Here, E2F1 is linked to squamous cell carcinoma.